Total Knee Arthroplasty

Global Total Knee Arthroplasty Market to Reach US$12.1 Billion by 2030

The global market for Total Knee Arthroplasty estimated at US$9.8 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Metal On Plastic Material, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Ceramic On Plastic Material segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 6.7% CAGR

The Total Knee Arthroplasty market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global "Total Knee Arthroplasty" Market – Key Trends & Drivers Summarized

Why Is Total Knee Arthroplasty Becoming an Increasingly Common Surgical Intervention?

Total Knee Arthroplasty (TKA), also known as total knee replacement, is becoming one of the most frequently performed orthopedic procedures worldwide, reflecting a rising burden of degenerative joint diseases and a global aging population. The increase in life expectancy, combined with growing incidences of osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis, has significantly expanded the candidate pool for TKA procedures. Particularly in developed countries, where access to advanced healthcare is widespread, patients are opting for surgery at younger ages to maintain active lifestyles. Improvements in surgical outcomes, including pain relief, mobility restoration, and high patient satisfaction, have encouraged more individuals to pursue early intervention rather than delay treatment. Additionally, public awareness campaigns and the influence of digital health platforms have empowered patients to seek timely orthopedic consultations. On the other hand, in emerging economies, rising disposable incomes and the gradual expansion of healthcare infrastructure are enabling wider access to joint replacement surgeries, fostering a growing middle-class demand for quality-of-life enhancing procedures like TKA.

How Are Technological Advances Reshaping the Scope and Precision of Knee Replacement Surgeries?

The Total Knee Arthroplasty market is being significantly transformed by technological advancements aimed at improving surgical accuracy, patient outcomes, and implant longevity. Robotic-assisted surgery, patient-specific instrumentation (PSI), and computer-aided navigation systems are reducing variability in component alignment and soft tissue balance—factors critical to implant success and long-term function. These systems also shorten recovery times and reduce revision rates by enhancing precision and minimizing intraoperative errors. Furthermore, innovations in implant materials, such as oxidized zirconium and highly cross-linked polyethylene, are extending prosthetic lifespans and reducing wear-related complications. Cementless implants, 3D-printed components, and biologically compatible coatings are offering better osseointegration and customization for patients with complex anatomy. The use of data analytics and artificial intelligence is allowing orthopedic surgeons to create personalized treatment pathways, based on patient-specific risk factors and kinematics. All of these advancements are positioning TKA as a safer, more efficient, and increasingly outpatient-compatible procedure, reshaping the way orthopedic care is delivered in hospitals and ambulatory surgery centers.

Is the Shift Toward Outpatient and Minimally Invasive Procedures Restructuring Care Delivery Models?

Yes, the increasing transition from inpatient to outpatient settings is fundamentally altering the delivery model of Total Knee Arthroplasty. Enhanced recovery protocols (ERPs), coupled with minimally invasive surgical techniques, are reducing hospital stays from multiple days to same-day discharge in many cases. This shift is driven by both patient preference and healthcare provider incentives to reduce costs and resource utilization. Ambulatory Surgery Centers (ASCs) are now equipped to handle complex joint replacements, supported by real-time monitoring, tele-rehabilitation services, and rapid post-op recovery plans. This transition is particularly prominent in the United States, where regulatory changes and value-based care models are accelerating outpatient joint replacements. Additionally, wearable health technologies and mobile applications are playing a pivotal role in post-surgical monitoring, allowing clinicians to track patient progress, manage pain, and adjust physiotherapy remotely. These innovations not only increase patient engagement and satisfaction but also decrease the likelihood of readmissions. As healthcare systems prioritize efficiency and outcomes, outpatient TKA procedures are expected to dominate in volume, with more hospitals forming partnerships with ASCs and digital health platforms.

What’s Propelling the Growth Trajectory of the Total Knee Arthroplasty Market?

SCOPE OF STUDY:

The report analyzes the Total Knee Arthroplasty market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Material (Metal On Plastic, Ceramic On Plastic, Ceramic On Ceramic, Metal On Metal); Implant Type (Fixed Bearing, Mobile Bearing); End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Aesculap Implant Systems
• Amplitude Surgical
• Arthrex, Inc.
• B. Braun Melsungen AG
• Conformis, Inc.
• Corin Group
• DePuy Synthes (Johnson & Johnson)
• Exactech, Inc.
• FH Orthopedics
• Globus Medical, Inc.
• LimaCorporate
• Medacta International
• MicroPort Orthopedics Inc.
• OMNIlife science, Inc.
• Ortho Development Corporation
• Smith & Nephew plc
• Stryker Corporation
• United Orthopedic Corporation
• Waldemar Link GmbH & Co. KG
• Zimmer Biomet Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.